These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 26391050)

  • 21. Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
    Gautier MK; Kelley CM; Lee SH; Alldred MJ; McDaid J; Mufson EJ; Stutzmann GE; Ginsberg SD
    Neurobiol Dis; 2023 Nov; 188():106332. PubMed ID: 37890559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gait dyspraxia as a clinical marker of cognitive decline in Down syndrome: A review of theory and proposed mechanisms.
    Anderson-Mooney AJ; Schmitt FA; Head E; Lott IT; Heilman KM
    Brain Cogn; 2016 Apr; 104():48-57. PubMed ID: 26930369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving Memory and Cognition in Individuals with Down Syndrome.
    Rafii MS
    CNS Drugs; 2016 Jul; 30(7):567-73. PubMed ID: 27272473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse models for Down syndrome-associated developmental cognitive disabilities.
    Liu C; Belichenko PV; Zhang L; Fu D; Kleschevnikov AM; Baldini A; Antonarakis SE; Mobley WC; Yu YE
    Dev Neurosci; 2011; 33(5):404-13. PubMed ID: 21865664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
    Raha-Chowdhury R; Henderson JW; Raha AA; Stott SRW; Vuono R; Foscarin S; Wilson L; Annus T; Fincham R; Allinson K; Devalia V; Friedland RP; Holland A; Zaman SH
    J Alzheimers Dis; 2018; 61(3):1143-1162. PubMed ID: 29278889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.
    Levine S; Saltzman A; Levy E; Ginsberg SD
    Exp Mol Pathol; 2009 Feb; 86(1):18-22. PubMed ID: 19041304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.
    Hamlett ED; Hjorth E; Ledreux A; Gilmore A; Schultzberg M; Granholm AC
    Glia; 2020 Jul; 68(7):1347-1360. PubMed ID: 31944407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways to cognitive deficits in Down syndrome.
    Sturgeon X; Le T; Ahmed MM; Gardiner KJ
    Prog Brain Res; 2012; 197():73-100. PubMed ID: 22541289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyubiquitinylation Profile in Down Syndrome Brain Before and After the Development of Alzheimer Neuropathology.
    Tramutola A; Di Domenico F; Barone E; Arena A; Giorgi A; di Francesco L; Schininà ME; Coccia R; Head E; Butterfield DA; Perluigi M
    Antioxid Redox Signal; 2017 Mar; 26(7):280-298. PubMed ID: 27627691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroanatomy of Down syndrome in vivo: a model of preclinical Alzheimer's disease.
    Teipel SJ; Hampel H
    Behav Genet; 2006 May; 36(3):405-15. PubMed ID: 16485178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
    Alldred MJ; Lee SH; Petkova E; Ginsberg SD
    J Comp Neurol; 2015 Jan; 523(1):61-74. PubMed ID: 25131634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's disease.
    Shim KS; Ferrando-Miguel R; Lubec G
    J Neural Transm Suppl; 2003; (67):39-49. PubMed ID: 15068237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome.
    Jenkins EC; Ye L; Gu H; Ni SA; Duncan CJ; Velinov M; Pang D; Krinsky-McHale SJ; Zigman WB; Schupf N; Silverman WP
    Neurosci Lett; 2008 Aug; 440(3):340-3. PubMed ID: 18571319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
    Castro P; Zaman S; Holland A
    J Neurol; 2017 Apr; 264(4):804-813. PubMed ID: 27778163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RCAN1 knockout and overexpression recapitulate an ensemble of rest-activity and circadian disruptions characteristic of Down syndrome, Alzheimer's disease, and normative aging.
    Wong H; Buck JM; Borski C; Pafford JT; Keller BN; Milstead RA; Hanson JL; Stitzel JA; Hoeffer CA
    J Neurodev Disord; 2022 May; 14(1):33. PubMed ID: 35610565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21.
    Cannavo C; Tosh J; Fisher EMC; Wiseman FK
    Prog Brain Res; 2020; 251():181-208. PubMed ID: 32057307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome.
    Velazquez R; Ash JA; Powers BE; Kelley CM; Strawderman M; Luscher ZI; Ginsberg SD; Mufson EJ; Strupp BJ
    Neurobiol Dis; 2013 Oct; 58():92-101. PubMed ID: 23643842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurobiological elements of cognitive dysfunction in down syndrome: exploring the role of APP.
    Millan Sanchez M; Heyn SN; Das D; Moghadam S; Martin KJ; Salehi A
    Biol Psychiatry; 2012 Mar; 71(5):403-9. PubMed ID: 21945306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signalling Pathways Implicated in Alzheimer's Disease Neurodegeneration in Individuals with and without Down Syndrome.
    Martínez-Cué C; Rueda N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.